Literature DB >> 19201396

Macrophage-derived interleukin-6 up-regulates MUC1, but down-regulates MUC2 expression in the human colon cancer HT-29 cell line.

Ying-Ying Li1, Ling-Ling Hsieh, Rei-Ping Tang, Shuen-Keui Liao, Kun-Yun Yeh.   

Abstract

Little is known regarding the effects of IL-6 released by tumor-infiltrating macrophages on the mucin expression of colon cancer cells. We isolated macrophages from healthy donors and harvested the supernatant after 48-h cultures. Using flow cytometry and intracellular staining methods, we found that macrophage supernatant effectively induced MUC1 up-regulation and MUC2 down-regulation of colon cancer cells in vitro. Western blotting analysis using monoclonal antibody against IL-6 or gp 130 verified that this IL-6-driven activity was through the activation of tyrosine phosphorylation (Tyr(705)) of STAT3 in cancer cells. We analyzed the surgical specimens of 29 patients with colon cancer by an immunohistochemical staining method and demonstrated the co-localization of macrophages, and the expression of IL-6, CD68, and MUC1 in colon cancer patients. Therefore, macrophage-derived IL-6 modulates the mucin expression of colorectal cancer cells that might in turn produce a permissive milieu favorable to cancer spread.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19201396     DOI: 10.1016/j.cellimm.2009.01.001

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  14 in total

1.  TNF-α is a key regulator of MUC1, an anti-inflammatory molecule, during airway Pseudomonas aeruginosa infection.

Authors:  Seongwon Choi; Yong Sung Park; Takeshi Koga; Allison Treloar; Kwang Chul Kim
Journal:  Am J Respir Cell Mol Biol       Date:  2010-05-06       Impact factor: 6.914

2.  Aberrant DNA methylation profile in cholangiocarcinoma.

Authors:  Li Huang; Gabriel Frampton; Li-Jian Liang; Sharon Demorrow
Journal:  World J Gastrointest Pathophysiol       Date:  2010-06-15

Review 3.  Mechanisms of antitumor and immune-enhancing activities of MUC1/sec, a secreted form of mucin-1.

Authors:  Dan Ilkovitch; Roberto Carrio; Diana M Lopez
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

4.  MUC2 polymorphisms are associated with endometriosis development and infertility: a case-control study.

Authors:  Cherry Yin-Yi Chang; Yi Chen; Wu-Chou Lin; Chih-Mei Chen; Chih-Ping Chen; Shan-Chih Lee; Jim Jinn-Chyuan Sheu; Fuu-Jen Tsai
Journal:  BMC Med Genet       Date:  2012-03-15       Impact factor: 2.103

5.  Suppression of mucin 2 promotes interleukin-6 secretion and tumor growth in an orthotopic immune-competent colon cancer animal model.

Authors:  Yan-Shen Shan; Hui-Ping Hsu; Ming-Derg Lai; Meng-Chi Yen; Jung-Hua Fang; Tzu-Yang Weng; Yi-Ling Chen
Journal:  Oncol Rep       Date:  2014-10-13       Impact factor: 3.906

6.  MUC1-ARF-A Novel MUC1 Protein That Resides in the Nucleus and Is Expressed by Alternate Reading Frame Translation of MUC1 mRNA.

Authors:  Michael Chalick; Oded Jacobi; Edward Pichinuk; Christian Garbar; Armand Bensussan; Alan Meeker; Ravit Ziv; Tania Zehavi; Nechama I Smorodinsky; John Hilkens; Franz-Georg Hanisch; Daniel B Rubinstein; Daniel H Wreschner
Journal:  PLoS One       Date:  2016-10-21       Impact factor: 3.240

7.  Role of integrin-linked kinase in regulating the protein stability of the MUC1-C oncoprotein in pancreatic cancer cells.

Authors:  H-L Huang; H-Y Wu; P-C Chu; I-L Lai; P-H Huang; S K Kulp; S-L Pan; C-M Teng; C-S Chen
Journal:  Oncogenesis       Date:  2017-07-10       Impact factor: 7.485

8.  A High Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury during the COVID-19 pandemic.

Authors:  Maria Alimova; Eriene-Heidi Sidhom; Abhigyan Satyam; Moran Dvela-Levitt; Michelle Melanson; Brian T Chamberlain; Seth L Alper; Jean Santos; Juan Gutierrez; Ayshwarya Subramanian; Elizabeth Grinkevich; Estefania Reyes Bricio; Choah Kim; Abbe Clark; Andrew Watts; Rebecca Thompson; Jamie Marshall; Juan Lorenzo Pablo; Juliana Coraor; Julie Roignot; Katherine A Vernon; Keith Keller; Alissa Campbell; Maheswarareddy Emani; Matthew Racette; Silvana Bazua-Valenti; Valeria Padovano; Astrid Weins; Stephen P McAdoo; Frederick W K Tam; Lucienne Ronco; Florence Wagner; George C Tsokos; Jillian L Shaw; Anna Greka
Journal:  bioRxiv       Date:  2020-06-30

Review 9.  STAT3-Activating Cytokines: A Therapeutic Opportunity for Inflammatory Bowel Disease?

Authors:  Paul M Nguyen; Tracy L Putoczki; Matthias Ernst
Journal:  J Interferon Cytokine Res       Date:  2015-03-11       Impact factor: 2.607

10.  Mucin 2 silencing promotes colon cancer metastasis through interleukin-6 signaling.

Authors:  Hui-Ping Hsu; Ming-Derg Lai; Jenq-Chang Lee; Meng-Chi Yen; Tzu-Yang Weng; Wei-Ching Chen; Jung-Hua Fang; Yi-Ling Chen
Journal:  Sci Rep       Date:  2017-07-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.